Flagchem(300575)

Search documents
中旗股份(300575) - 2017年2月13日投资者关系活动记录表(一)
2022-12-05 05:42
编号:2017-02 证券代码:300575 证券简称:中旗股份 江苏中旗作物保护股份有限公司投资者关系活动记录表 | --- | --- | --- | |-----------------------|------------------------------|--------------------------------------------------------------| | | | | | 投资者关系 | □ 特定对象调研 | □ 分析师会议 | | 活动类别 | □ 媒体采访 | □ 业绩说明会 | | | □ 新闻发布会 | □ 路演活动 | | | □ 现场参观 | | | | □ | 其他 (请文字说明其他活动内容) | | 参与单位名称 | 弢瑞资产 曾正香 | | | 及人员姓名 | | | | 时间 | 2017.2.13 下午 3:00 | | | 地点 | 江苏南京化学工业园区长丰河路 | 309 号公司会议室 | | | | | | 上市公司 接待人员姓名 | | 董事副总经理兼董事会秘书丁阳、证券部徐利 | | 投资者关系活 | 一、公司介绍 | | | 动主要内容 ...
中旗股份(300575) - 2017年9月15日投资者关系活动记录表
2022-12-05 01:54
证券代码:300575 证券简称:中旗股份 江苏中旗作物保护股份有限公司投资者关系活动记录表 编号:2017-08 | --- | --- | --- | --- | |-----------------------|-------------------------|------------------------------------------|-----------------------------------------------------------------| | | | | | | 投资者关系 | | □特定对象调研 □分析师会议 □媒体采访 | | | 活动类别 | □ | 业绩说明会 □新闻发布会 □路演活动 | | | | □现场参观 | □ | 其他 (请文字说明其他活动内容) | | 参与单位名称 | 国泰君安 陈煜 杨雪松 | | | | 及人员姓名 | | | | | 时间 | 2017 年 9 月 15 | 日 | | | 地点 | | 江苏南京玄武区徐庄软件园苏园路 | 6 号 2 栋会议室 | | 上市公司 接待人员姓名 | | | 董事副总经理兼董事会秘书 丁阳 ...
中旗股份(300575) - 2017年8月24日投资者关系活动记录表
2022-12-05 01:50
编号:2017-07 证券代码:300575 证券简称:中旗股份 江苏中旗作物保护股份有限公司投资者关系活动记录表 | --- | --- | --- | |--------------|-------------------------|------------------------------------------------------------------| | | | | | 投资者关系 | | □特定对象调研 □分析师会议 □媒体采访 | | 活动类别 | □ | 业绩说明会 □新闻发布会 □路演活动 | | | □现场参观 | □ 其他 (请文字说明其他活动内容) | | 参与单位名称 | | 东北证券 邹兰兰 东北证券 李楠竹 东方证券资管 蔡志鹏 | | 及人员姓名 | 天弘基金 杨大志 | 长信基金 朱 垚 华泰保兴基金 黄佳丽 申万宏源 陈俊杰 | | 时间 | 2017 年 8 月 24 | 日 | | 地点 | | 江苏南京化学工业园区公司研发中心及生产基地 | | 上市公司 | | | | 接待人员姓名 | | 董事副总经理兼董事会秘书 丁阳、证券事务代表 徐利 | | 投资 ...
中旗股份(300575) - 2018年1月5日投资者关系活动记录表
2022-12-04 08:44
编号:2018-01 证券代码:300575 证券简称:中旗股份 江苏中旗科技股份有限公司投资者关系活动记录表 | --- | --- | --- | |--------------|----------------------------------|----------------------------------------------------------------| | | | | | 投资者关系 | □ | 特定对象调研 □分析师会议 □媒体采访 | | 活动类别 | | □业绩说明会 □新闻发布会 □路演活动 | | | □ 现场参观 | □其他 (请文字说明其他活动内容) | | 参与单位名称 | 东兴证券 罗四维 新时代证券 李啸 | | | 及人员姓名 | | | | 时间 | 2018 年 01 月 05 日 | | | 地点 | 江苏南京玄武区徐庄软件园苏园路 | 6 号 2 栋会议室 | | 上市公司 | | 董事副总经理兼董事会秘书 丁阳、证券事务代表 徐利 | | 接待人员姓名 | | | | 投资者关系活 | 投资者互动问答: | | | 动主要内容介 | Q1 | :预 ...
中旗股份(300575) - 2017年10月26日投资者关系活动记录表
2022-12-04 08:32
编号:2017-10 证券代码:300575 证券简称:中旗股份 江苏中旗科技股份有限公司投资者关系活动记录表 | --- | --- | --- | |--------------|----------------------------------------|----------------------------------------------------------------| | 投资者关系 | □ | 特定对象调研 □分析师会议 □媒体采访 | | 活动类别 | □ | 业绩说明会 □新闻发布会 □路演活动 | | | □ 现场参观 | □其他 (请文字说明其他活动内容) | | 参与单位名称 | | 嘉实基金 吴云峰 苏文 杰付赫 工银瑞信基金 高京霞 | | 及人员姓名 | | 国泰君安 黄恂怡 杉树资产 沈杰 申万宏源 陈俊杰 | | 时间 | 2017 年 10 月 26 | | | 地点 | 江苏南京玄武区徐庄软件园苏园路 | 6 号 2 栋会议室 | | 上市公司 | | 董事副总经理兼董事会秘书 丁阳、证券事务代表 徐利 | | 接待人员姓名 | | | | 投资者关系活 | ...
中旗股份(300575) - 2017年10月18日投资者关系活动记录表
2022-12-04 07:02
编号:2017-09 证券代码:300575 证券简称:中旗股份 | --- | --- | --- | --- | |-----------------------|----------------------------------|-------|----------------------------------------------------------------| | 投资者关系 | □ | | 特定对象调研 □分析师会议 □媒体采访 | | 活动类别 | □ | | 业绩说明会 □新闻发布会 □路演活动 | | | □ 现场参观 | | □其他 (请文字说明其他活动内容) | | 参与单位名称 | | | 浙商证券 曹承安 沈忱 华夏基金 杨晋 北猿资本 林辉云 | | 及人员姓名 | | | | | 时间 | 2017 年 10 月 18 | 日 | | | 地点 | 江苏南京玄武区徐庄软件园苏园路 | 6 | 号 2 栋会议室 | | 上市公司 接待人员姓名 | | | 董事副总经理兼董事会秘书 丁阳、证券事务代表 徐利 | | 投资者关系活 | 投资者互动问答: | | | | 动主 ...
中旗股份(300575) - 2017年11月8日投资者关系活动记录表
2022-12-04 06:54
编号:2017-11 证券代码:300575 证券简称:中旗股份 江苏中旗科技股份有限公司投资者关系活动记录表 | --- | --- | --- | |--------------|------------------------------------|------------------------------------------------------------------| | | | | | 投资者关系 | □ | 特定对象调研 □分析师会议 □媒体采访 | | 活动类别 | □ | 业绩说明会 □新闻发布会 □路演活动 | | | □ 现场参观 | □其他 (请文字说明其他活动内容) | | 参与单位名称 | 华创证券 曹令 陈凯茜 国都证券 王双 | | | 及人员姓名 | | 西南证券 商艾华 李海勇 国金证券 霍堃 孙蔚 | | 时间 | 2017 年 11 月 08 | | | 地点 | 江苏南京玄武区徐庄软件园苏园路 | 6 号 2 栋会议室 | | 上市公司 | | 董事副总经理兼董事会秘书 丁阳、证券事务代表 徐利 | | 接待人员姓名 | | | | 投资者关系活 | 一、 ...
中旗股份(300575) - 2018年5月17日投资者关系活动记录表
2022-12-03 09:48
编号:2018-02 证券代码:300575 证券简称:中旗股份 江苏中旗科技股份有限公司投资者关系活动记录表 | --- | --- | --- | --- | --- | |-------------------------|--------------------------|----------------------------------------------------|----------------------------------|--------------------------------------------------------------------| | | | | | | | 投资者关系 | □ | 特定对象调研 □分析师会议 □媒体采访 | | | | 活动类别 | □ | 业绩说明会 □新闻发布会 □路演活动 | | | | | □ 现场参观 | | □其他 (请文字说明其他活动内容) | | | | | | | 南方基金 张磊 华泰证券 刘曦 易方达基金 张琦 征金资本 李瀚昊 | | 参与单位名称 及人员姓名 | | | | 天风证券 吴頔 沣杨资产 吴亮 ...
中旗股份(300575) - 2022 Q3 - 季度财报
2022-10-25 16:00
Financial Performance - The company's revenue for Q3 2022 reached ¥822,507,457.36, representing a 37.72% increase year-over-year[5] - Net profit attributable to shareholders was ¥120,210,685.84, a significant increase of 252.90% compared to the same period last year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥128,993,387.53, up 285.49% year-over-year[5] - The total operating revenue for the period reached ¥2,164,838,253.82, an increase of 43.6% compared to ¥1,508,120,820.92 in the previous period[21] - The operating profit for the current period was ¥352,696,973.25, significantly higher than ¥142,871,837.65 from the previous period, reflecting a growth of 146.5%[21] - The net profit for Q3 2022 was CNY 303,003,945.40, a significant increase of 137.8% compared to CNY 127,313,498.08 in Q3 2021[22] - The total comprehensive income for the period was CNY 303,003,945.40, reflecting a strong performance compared to CNY 127,313,498.08 in the previous year[22] Cash Flow and Assets - Cash flow from operating activities showed a net increase of ¥477,768,131.46, reflecting a 455.11% increase compared to the previous year[9] - Cash and cash equivalents increased to ¥518,699,113.76 from ¥402,274,277.19, representing a growth of 29%[18] - Cash and cash equivalents at the end of the period totaled CNY 365,356,728.03, an increase from CNY 250,425,949.38 at the end of Q3 2021[24] - The net cash flow from operating activities was CNY 477,768,131.46, compared to CNY 86,067,193.90 in Q3 2021, marking a substantial increase[23] - The cash flow from investment activities was negative at CNY -481,791,626.44, worsening from CNY -284,710,185.63 in Q3 2021[23] Shareholder Information - Total number of common stock shareholders at the end of the reporting period is 8,561[11] - Wu Yaojun holds 28.84% of shares, totaling 89,407,395 shares, with 67,055,545 shares pledged[11] - Zhang Ji holds 5.75% of shares, totaling 17,820,000 shares[11] - The top 10 shareholders include various funds and banks, with the largest being Wu Yaojun[12] - The total number of restricted shares at the end of the period is 85,537,495[15] - Wu Yaojun's locked shares are subject to a transfer limit of 25% of his total holdings per year[15] - The company has not disclosed any related party relationships among other shareholders[12] - No shareholders among the top 10 are participating in margin financing[12] - The company has a total of 4,164,750 shares under equity incentive restrictions[15] - The report indicates that the company is under high management lock-up for certain shares[15] Expenses and Liabilities - The total operating costs amounted to ¥1,792,099,353.03, up 31.2% from ¥1,366,226,419.28 in the prior period[21] - The company's long-term equity investments rose to ¥75,044,197.49 from ¥47,449,583.71, marking an increase of 58.5%[18] - The total liabilities increased to ¥1,808,761,254.28 from ¥1,491,764,337.65, reflecting a rise of 21.2%[19] - The company incurred operating expenses of CNY 1,358,244,254.98, which is an increase from CNY 1,058,220,385.48 in Q3 2021[23] Research and Development - Research and development expenses rose to ¥49,077,728.71, marking a 32.77% increase due to higher investment in R&D[9] Borrowings and Investments - The company reported a significant increase in long-term borrowings, which rose by 74.25% to ¥687,748,249.74, primarily for new project financing[9] - The company is in the process of acquiring 100% equity of Jiangsu Sukeno Agricultural Chemical Co., Ltd., with a confirmed transaction amount of ¥11 million[16] Receivables and Inventory - The company experienced a 73.01% increase in receivables financing, totaling ¥32,582,828.13, due to an increase in received notes[9] - The company reported a decrease in inventory from ¥360,561,399.70 to ¥316,712,594.44, a reduction of 12.1%[18]
中旗股份(300575) - 2022 Q2 - 季度财报
2022-08-17 16:00
Financial Performance - The company's operating revenue for the first half of 2022 was CNY 1,342,330,796.46, representing a 47.37% increase compared to CNY 910,872,470.00 in the same period last year[24]. - Net profit attributable to shareholders was CNY 179,199,164.97, a 94.14% increase from CNY 92,302,635.17 year-on-year[24]. - The net profit after deducting non-recurring gains and losses was CNY 179,659,042.54, up 109.31% from CNY 85,832,690.85 in the previous year[24]. - The net cash flow from operating activities reached CNY 343,323,216.91, a significant increase of 744.35% compared to CNY 40,661,252.27 in the same period last year[25]. - Basic earnings per share were CNY 0.58, reflecting a 93.33% increase from CNY 0.30 in the previous year[25]. - Total assets at the end of the reporting period were CNY 3,520,232,201.20, an increase of 11.59% from CNY 3,154,713,796.81 at the end of the previous year[25]. - The net assets attributable to shareholders increased to CNY 1,802,047,218.17, up 8.79% from CNY 1,656,487,679.47 at the end of the previous year[25]. Corporate Governance and Transparency - The company reported no cash dividends, stock bonuses, or capital reserve transfers to increase share capital for the period[4]. - The financial report is guaranteed to be true, accurate, and complete by the board of directors and management[3]. - The company has a commitment to transparency in its financial disclosures and has made all relevant documents available for public access[10]. - The company has not reported any changes in its information disclosure practices during the reporting period[19]. - The company emphasizes the importance of reading the full report, especially the section on risks and countermeasures[3]. Research and Development - The company holds 81 authorized patents, including 53 invention patents, showcasing its strong technological capabilities[38]. - The company has developed over 600 pesticide active ingredients, indicating a diverse product portfolio[39]. - Research and development expenses increased by 36.20% to ¥30,712,666.48, reflecting increased investment in R&D projects[44]. - Research and development expenses for the first half of 2022 were CNY 30,712,666.48, up from CNY 22,549,211.32 in the same period last year, indicating a growth of 36.2%[160]. Market Position and Strategy - The global agricultural chemical industry is experiencing increased demand due to geopolitical tensions and rising food security concerns, which is expected to benefit the company's market position[33]. - The company is positioned in a growth phase within the pesticide industry, which is characterized by rigid demand in downstream sectors[38]. - The company plans to expand its market presence and invest in new product development to sustain growth momentum in the upcoming quarters[160]. - The company plans to introduce two new product lines in the next quarter, aiming to capture emerging market segments[184]. - The company has set a performance guidance of 15% revenue growth for the next fiscal year, driven by new product launches and market expansion[172]. Environmental Compliance - The company reported a total COD discharge of 31.32 tons, with a concentration of 142.55 mg/L, against a standard limit of 500 mg/L[88]. - The company has established a wastewater treatment station that operates under a "one enterprise, one pipe" discharge policy, ensuring compliance with discharge standards[89]. - The company has implemented advanced wastewater treatment technologies, including high-efficiency catalytic oxidation and MBBR systems, to enhance treatment efficiency[89]. - The company has established a dedicated environmental management organization to oversee compliance with environmental regulations[89]. Financial Management - The company has not disclosed any significant asset or equity sales during the reporting period[21]. - The company has not engaged in any derivative investments during the reporting period[67]. - The company has maintained a stable financial position with no expected impairment on entrusted financial management[66]. - The company reported a net increase in cash and cash equivalents of ¥144,195,490.36, a 146.46% rise compared to the previous year, attributed to improved cash flow from operating and financing activities[44]. Shareholder Information - The largest shareholder, Wu Yaojun, holds 28.84% of the shares, totaling 89,407,395 shares, with a pledge of 22,351,850 shares[138]. - The second largest shareholder, Zhou Xuejin, owns 5.76% of the shares, amounting to 17,868,035 shares, with no changes reported[138]. - The report indicates that the company has not disclosed any significant changes in shareholder relationships or voting rights among the top ten shareholders[140]. - The company has seen a significant increase in shareholding from institutional investors, indicating growing confidence in its performance[139]. Risk Management - The company faced significant risks related to raw material supply and price fluctuations, which heavily impacted operating costs and gross margins[72]. - Environmental protection and safety production risks were highlighted, with potential impacts on operations due to stricter regulations and the nature of the chemical industry[72]. - Foreign exchange risk management strategies include export trade financing and the use of foreign exchange derivatives to address the high proportion of overseas sales revenue[74]. Operational Efficiency - The company has implemented a flexible production mechanism, allowing for quick adaptation to market demands while maintaining product quality[41]. - The gross profit margin in the pesticide industry was 23.84%, up from 21.81% in the previous year, indicating improved profitability[46]. - The overall operating margin improved to 15%, reflecting better cost management and operational efficiency[172]. Social Responsibility - The company actively participates in social responsibility initiatives, including volunteer activities related to public health[97]. - The company emphasizes employee training and development, providing various training programs to enhance staff skills and knowledge[96].